Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Folge dem Geld: Methan im Fokus der COP31!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
EP

WKN: 634826 | ISIN: US28659T2006 | Ticker: ETF
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
ELITE PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
ELITE PHARMACEUTICALS INC 5-Tage-Chart

Aktuelle News zur ELITE PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrEarnings Call: Elite Pharmaceuticals steigert Umsatz im zweiten Quartal um 10 % - Aktie legt kräftig zu13
ELITE PHARMACEUTICALS Aktie jetzt für 0€ handeln
12.11.Elite Pharmaceuticals reports Q2 results2
12.11.Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2027 ended September 30, 2026 and Provides Conference Call Information478Conference Call Scheduled for Friday, November 13, 2026 at 11:30 AM ESTNorthvale, New Jersey--(Newsfile Corp. - November 12, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company")...
► Artikel lesen
12.11.ELITE PHARMACEUTICALS INC /NV/ - 8-K, Current Report1
12.11.ELITE PHARMACEUTICALS INC /NV/ - 10-Q, Quarterly Report1
10.11.Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter of Fiscal Year 2027 Financial Results on November 13, 2026480Financials for Second Quarter of Fiscal Year 2027 Ended September 30, 2026 will be released on Thursday, November 12, 2026Northvale, New Jersey--(Newsfile Corp. - November 10, 2026) - Elite Pharmaceuticals...
► Artikel lesen
03.11.Elite Pharmaceuticals adds two directors to expanded board3
03.11.Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals Expands Board of Directors with Election of Aqeel A. Fatmi, Ph.D., and John W. LaRocca, Esq.488Northvale, New Jersey--(Newsfile Corp. - November 3, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products...
► Artikel lesen
03.11.ELITE PHARMACEUTICALS INC /NV/ - 8-K, Current Report2
14.08.Earnings Call: Umsatz von Elite Pharmaceuticals normalisiert sich in Q1 2027, Aktie fällt9
13.08.Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2027 Ended June 30, 2026 and Provides Conference Call Information656Northvale, New Jersey--(Newsfile Corp. - August 13, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products...
► Artikel lesen
13.08.ELITE PHARMACEUTICALS INC /NV/ - 10-Q, Quarterly Report2
10.08.Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter of Fiscal Year 2027 Financial Results on August 14, 2026621Northvale, New Jersey--(Newsfile Corp. - August 10, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products...
► Artikel lesen
04.08.ELITE PHARMACEUTICALS INC /NV/ - 8-K, Current Report4
04.08.Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals Announces Commercial Launch of Generic Requip XL274Northvale, New Jersey--(Newsfile Corp. - August 4, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products...
► Artikel lesen
02.07.Elite Pharmaceuticals Reports Q4 2026 Results: Full Earnings Call Transcript2
01.07.Elite Pharmaceuticals outlines ropinirole launch next month and targets 5% to 10% of its $12M market2
29.06.Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2026 and Provides Conference Call Information1.631Northvale, New Jersey--(Newsfile Corp. - June 29, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products...
► Artikel lesen
29.06.Elite Pharmaceuticals GAAP EPS of $0.03, revenue of $148.87M2
29.06.ELITE PHARMACEUTICALS INC /NV/ - 10-K, Annual Report5
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1